Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-Current Assets (2019 - 2025)

Biodesix's Non-Current Assets history spans 7 years, with the latest figure at $55.0 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 4.85% year-over-year to $55.0 million; the TTM value through Dec 2025 reached $55.0 million, down 4.85%, while the annual FY2025 figure was $55.0 million, 4.85% down from the prior year.
  • Non-Current Assets reached $55.0 million in Q4 2025 per BDSX's latest filing, down from $55.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $59.4 million in Q4 2023 to a low of $32.5 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $47.9 million, with a median of $53.7 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: decreased 7.0% in 2021, then skyrocketed 50.14% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $32.5 million in 2021, then grew by 21.82% to $39.6 million in 2022, then surged by 50.14% to $59.4 million in 2023, then dropped by 2.78% to $57.8 million in 2024, then dropped by 4.85% to $55.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Non-Current Assets are $55.0 million (Q4 2025), $55.3 million (Q3 2025), and $55.3 million (Q2 2025).